A new study from UCSF reveals that a common gut bacterium, Gammaproteobacteria, may undermine the effectiveness of gemcitabine chemotherapy in pancreatic cancer patients. This discovery could revolutionize treatment approaches and highlights the complex interplay between our gut microbiome and cancer therapy.

DNN | The Daily News Now!

The world’s first global local news network.

Every city. Every story. AI powered. 

---

Hosted on Acast. See acast.com/privacy for more information.